Darrell C Haynes

Title: The Innovations of Darrell C. Haynes

Introduction

Darrell C. Haynes is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of immunoassays, particularly through his innovative use of glycosaminoglycans. His work has implications for improving the accuracy and reliability of diagnostic tests.

Latest Patents

Haynes holds a patent for the "Use of glycosaminoglycans to reduce non-specific binding in immunoassays." This patent describes an immunoassay reagent that includes an analyte binding agent in a diluent, along with a glycosaminoglycan that effectively reduces non-specific binding during the assay process. Specifically, the analyte in question is troponin I, and the binding agent is a biotinylated anti-troponin I antibody, with chondroitin sulfate serving as the glycosaminoglycan. This innovation enhances the detection of analytes in various samples, thereby improving diagnostic accuracy.

Career Highlights

Darrell C. Haynes has had a successful career at Ortho-Clinical Diagnostics, Inc., where he has applied his expertise in immunoassays. His work has contributed to advancements in diagnostic technologies, making significant impacts in the medical field.

Collaborations

Haynes has collaborated with notable colleagues, including Banumathi Sankaran and Sheryl S. Sullivan. These partnerships have fostered a collaborative environment that encourages innovation and the development of new diagnostic solutions.

Conclusion

Darrell C. Haynes is a distinguished inventor whose work in immunoassays has led to important advancements in diagnostic testing. His innovative approach to reducing non-specific binding has the potential to enhance the accuracy of medical diagnostics significantly.